Susquehanna International Group’s VanEck Vectors Generic Drugs ETF GNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,614
Closed -$257K 5368
2019
Q1
$257K Buy
+11,614
New +$257K ﹤0.01% 2378